Literature DB >> 16849628

Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production.

Marion A M den Boer1, Peter J Voshol, Folkert Kuipers, Johannes A Romijn, Louis M Havekes.   

Abstract

Insulin is an important inhibitor of both hepatic glucose output and hepatic VLDL-triglyceride (VLDL-TG) production. We investigated whether both processes are equally sensitive to insulin-mediated inhibition. To test this, we used euglycemic clamp studies with four increasing plasma concentrations of insulin in wild-type C57Bl/6 mice. By extrapolation, we estimated that half-maximal inhibition of hepatic glucose output and hepatic VLDL-TG production by insulin were obtained at plasma insulin levels of approximately 3.6 and approximately 6.8 ng/ml, respectively. In the same experiments, we measured that half-maximal decrease of plasma free fatty acid levels and half-maximal stimulation of peripheral glucose uptake were reached at plasma insulin levels of approximately 3.0 and approximately 6.0 ng/ml, respectively. We conclude that, compared with insulin sensitivity of hepatic glucose output, peripheral glucose uptake and hepatic VLDL-TG production are less sensitive to insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849628     DOI: 10.1152/ajpendo.00188.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  14 in total

1.  High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity.

Authors:  Sjoerd Aa van den Berg; Bruno Guigas; Silvia Bijland; Margriet Ouwens; Peter J Voshol; Rune R Frants; Louis M Havekes; Johannes A Romijn; Ko Willems van Dijk
Journal:  Nutr Metab (Lond)       Date:  2010-03-27       Impact factor: 4.169

Review 2.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

3.  Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms.

Authors:  Célia Roger; Chloé Buch; Tania Muller; Julia Leemput; Laurent Demizieux; Patricia Passilly-Degrace; Resat Cinar; Malliga R Iyer; George Kunos; Bruno Vergès; Pascal Degrace; Tony Jourdan
Journal:  Diabetes       Date:  2020-07-17       Impact factor: 9.461

4.  Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice.

Authors:  Aki Uchida; Mikhail N Slipchenko; Ji-Xin Cheng; Kimberly K Buhman
Journal:  Biochim Biophys Acta       Date:  2011-01-06

5.  Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Authors:  Janet D Sparks; Colleen O'Dell; Jeffrey M Chamberlain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2013-05-15       Impact factor: 3.575

6.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.

Authors:  Adama Kamagate; Shen Qu; German Perdomo; Dongming Su; Dae Hyun Kim; Sandra Slusher; Marcia Meseck; H Henry Dong
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 7.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

8.  Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis.

Authors:  Irena Iankova; Carine Chavey; Cyrielle Clapé; Claude Colomer; Nathalie C Guérineau; Nicolas Grillet; Jean-François Brunet; Jean-Sébastien Annicotte; Lluis Fajas
Journal:  Endocrinology       Date:  2008-07-17       Impact factor: 4.736

9.  One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men.

Authors:  Gordon I Smith; Faidon Magkos; Dominic N Reeds; Adewole L Okunade; Bruce W Patterson; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2013-06-07       Impact factor: 5.958

10.  Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice.

Authors:  Aldo Grefhorst; Elizabeth J Parks
Journal:  J Lipid Res       Date:  2009-03-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.